BIOMAT Database Logo BIOMAT Database Logo

[Protective effect of thiamine propyldisulfate on experimental hepatic steatosis]. 1959

E PAROLI

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013831 Thiamine 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride. Aneurin,Vitamin B 1,Thiamin,Thiamine Mononitrate,Vitamin B1,Mononitrate, Thiamine

Related Publications

E PAROLI
Protective effect of lodoxamide on hepatic steatosis through GPR35.
January 2019, Cellular signalling,
E PAROLI
[Effect of administration of glucose and thiamine diphosphate on dietary hepatic steatosis].
January 1954, Il Farmaco; edizione scientifica,
E PAROLI
OCT1 in hepatic steatosis and thiamine disposition.
January 2015, Cell cycle (Georgetown, Tex.),
E PAROLI
[Effect of fasting on experimental hepatic steatosis in white rats].
January 1959, Comptes rendus des seances de la Societe de biologie et de ses filiales,
E PAROLI
[Case of massive hepatic steatosis secondary to thiamine abuse].
January 1986, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
E PAROLI
[Hepatic steatosis: experimental contribution].
July 1959, Maroc medical,
E PAROLI
[Protective effect of aspartic acid on experimental hepatic lesions].
January 1957, Revue internationale d'hepatologie,
E PAROLI
Effect of vildagliptin on hepatic steatosis.
April 2015, The Journal of clinical endocrinology and metabolism,
E PAROLI
GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis.
January 2020, BioMed research international,
E PAROLI
[Protective effect of dahuang zhechong pills on experimental hepatic injury].
November 1988, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
Copied contents to your clipboard!